Literature DB >> 17725652

Relationship between biofeedback and oxidative stress in patients with chronic migraine.

I Ciancarelli1, M G Tozzi-Ciancarelli, G Spacca, C Di Massimo, A Carolei.   

Abstract

Chronic migraine (1.5.1) is burdened with headache-related disability. During noxious stimulation, changes of cerebral blood flow enhance the release of oxygen free radicals that react with nitric oxide (NO). We investigated the role of biofeedback in limiting migraine disability by influencing oxidative stress. Peroxides, NO and superoxide dismutase (SOD) were analysed in 20 female subjects with chronic migraine and in 20 female healthy controls before and after biofeedback sessions. NO(x) levels (23.7 +/- 4.2 vs. 34.9 +/- 4.6 microm; P < 0.05) and SOD activity (6.5 +/- 1.0 vs. 8.0 +/- 0.7 U/ml; P < 0.05) were lower in migraine sufferers before treatment than in healthy controls, whereas peroxide levels (145.8 +/- 40.3 vs. 78.0 +/- 20.0 microm; P < 0.05) were higher in migraine sufferers before treatment than in healthy controls. In migraine sufferers NO(x) levels (23.7 +/- 4.2 vs. 31.3 +/- 7.1 microm; P < 0.05) and SOD activity (6.5 +/- 1.0 vs. 7.9 +/- 0.9 U/ml; P < 0.05) were lower before than after treatment, whereas peroxide levels (145.8 +/- 40.3 vs. 82.4 +/- 21.1 microm; P < 0.05) were higher before than after treatment. SOD serum activity correlated positively with NO(x) serum levels and negatively with peroxide serum levels in healthy controls and in chronic migraine sufferers before and after biofeedback. The mean Migraine Disability Assessment Score before biofeedback sessions was higher than after treatment (36.9 +/- 13.9 vs. 18.8 +/- 10.4; P < 0.001). The effectiveness of biofeedback in limiting chronic migraine may be related to muscular relaxation associated with decreased oxidative stress accompanied by psychological well-being.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17725652     DOI: 10.1111/j.1468-2982.2007.01398.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  11 in total

Review 1.  Integrative medicine: complementary therapies and supplements.

Authors:  Barrie R Cassileth; Jyothirmai Gubili; K Simon Yeung
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

2.  Paraoxonase 1 (PON1) polymorphisms and risk for migraine.

Authors:  Elena García-Martín; Carmen Martínez; Mercedes Serrador; Hortensia Alonso-Navarro; Francisco Navacerrada; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  J Neurol       Date:  2010-04-21       Impact factor: 4.849

3.  Identification of Determinants of Biofeedback Treatment's Efficacy in Treating Migraine and Oxidative Stress by ARIANNA (ARtificial Intelligent Assistant for Neural Network Analysis).

Authors:  Irene Ciancarelli; Giovanni Morone; Maria Giuliana Tozzi Ciancarelli; Stefano Paolucci; Paolo Tonin; Antonio Cerasa; Marco Iosa
Journal:  Healthcare (Basel)       Date:  2022-05-19

4.  Comparison of oxidative stress among migraineurs, tension-type headache subjects, and a control group.

Authors:  Ravi Gupta; Rahul Pathak; Manjeet Singh Bhatia; Basu Deb Banerjee
Journal:  Ann Indian Acad Neurol       Date:  2009-07       Impact factor: 1.383

5.  A novel oxidative stress marker in migraine patients: dynamic thiol-disulphide homeostasis.

Authors:  Sadiye Gumusyayla; Gonul Vural; Hesna Bektas; Salim Neselioglu; Orhan Deniz; Ozcan Erel
Journal:  Neurol Sci       Date:  2016-05-03       Impact factor: 3.307

Review 6.  Behavioral therapy for chronic migraine.

Authors:  Francesca Pistoia; Simona Sacco; Antonio Carolei
Journal:  Curr Pain Headache Rep       Date:  2013-01

7.  Lower serum bilirubin concentration in patients with migraine.

Authors:  Ling Cao; Li Xue; De-Mei Luo
Journal:  Int J Clin Exp Med       Date:  2015-08-15

8.  Plasma Levels of Oxidative Stress Markers, before and after BoNT/A Treatment, in Chronic Migraine.

Authors:  Elisa Dini; Sonia Mazzucchi; Ciro De Luca; Martina Cafalli; Lucia Chico; Annalisa Lo Gerfo; Gabriele Siciliano; Ubaldo Bonuccelli; Filippo Baldacci; Sara Gori
Journal:  Toxins (Basel)       Date:  2019-10-19       Impact factor: 4.546

9.  Mitochondrial function and oxidative stress markers in higher-frequency episodic migraine.

Authors:  Elena C Gross; Niveditha Putananickal; Anna-Lena Orsini; Deborah R Vogt; Peter S Sandor; Jean Schoenen; Dirk Fischer
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

Review 10.  The metabolic face of migraine - from pathophysiology to treatment.

Authors:  Elena C Gross; Marco Lisicki; Dirk Fischer; Peter S Sándor; Jean Schoenen
Journal:  Nat Rev Neurol       Date:  2019-10-04       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.